Inflammatory Abrasion of Hematopoietic Stem Cells: a Candidate Clue for the Post-CAR-T Hematotoxicity?

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2023 May 24

PMID 37223096

Authors

Ting Sun

Dengju Li

Liang Huang

Xiaojian Zhu

Affiliations

Soon will be listed here.

Abstract

Chimeric antigen receptor T-cell (CAR-T) therapy has shown remarkable effects in treating various hematological malignancies. However, hematotoxicity, specifically neutropenia, thrombocytopenia, and anemia, poses a serious threat to patient prognosis and remains a less focused adverse effect of CAR-T therapy. The mechanism underlying lasting or recurring late-phase hematotoxicity, long after the influence of lymphodepletion therapy and cytokine release syndrome (CRS), remains elusive. In this review, we summarize the current clinical studies on CAR-T late hematotoxicity to clarify its definition, incidence, characteristics, risk factors, and interventions. Owing to the effectiveness of transfusing hematopoietic stem cells (HSCs) in rescuing severe CAR-T late hematotoxicity and the unignorable role of inflammation in CAR-T therapy, this review also discusses possible mechanisms of the harmful influence of inflammation on HSCs, including inflammatory abrasion of the number and the function of HSCs. We also discuss chronic and acute inflammation. Cytokines, cellular immunity, and niche factors likely to be disturbed in CAR-T therapy are highlighted factors with possible contributions to post-CAR-T hematotoxicity.

Citing Articles

Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients.

Mingot-Castellano M, Reguera-Ortega J, Zafra Torres D, Hernani R, Lopez-Godino O, Guerreiro M J Clin Med. 2024; 13(17).

PMID: 39274330 PMC: 11396136. DOI: 10.3390/jcm13175117.

[Preparation of a dual-specific antibody targeting human CD123 and exploration of its anti-acute myeloid leukemia effects].

Zhou T, Chen M, Zhang C, Liu X, Wang Z, Xing H Zhonghua Xue Ye Xue Za Zhi. 2024; 45(3):225-232.

PMID: 38716593 PMC: 11078658. DOI: 10.3760/cma.j.cn121090-20231123-00272.

References

Caiado F, Pietras E, Manz M . Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection. J Exp Med. 2021; 218(7). PMC: 8210622. DOI: 10.1084/jem.20201541. View

Bodine D . Anemia of inflammation is all the RAGE. Blood. 2022; 139(21):3106-3107. DOI: 10.1182/blood.2021015337. View

Zhang G, Yang P, Liu X, Liu H, Wang J, Wang J . HMGB1 is increased in patients with immune thrombocytopenia and negatively associates with Tregs. Thromb Res. 2022; 213:128-136. DOI: 10.1016/j.thromres.2022.02.021. View

Crump M, Neelapu S, Farooq U, Van den Neste E, Kuruvilla J, Westin J . Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017; 130(16):1800-1808. PMC: 5649550. DOI: 10.1182/blood-2017-03-769620. View

Miller K, Johnson P, Abramson J, Soumerai J, Yee A, Branagan A . Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma. Blood Cancer J. 2022; 12(10):146. PMC: 9622902. DOI: 10.1038/s41408-022-00741-2. View

Bogeska R, Mikecin A, Kaschutnig P, Fawaz M, Buchler-Schaff M, Le D . Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging. Cell Stem Cell. 2022; 29(8):1273-1284.e8. PMC: 9357150. DOI: 10.1016/j.stem.2022.06.012. View

Alvarado L, Huntsman H, Cheng H, Townsley D, Winkler T, Feng X . Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ. Blood. 2019; 133(19):2043-2055. PMC: 6509545. DOI: 10.1182/blood-2018-11-884486. View

Zhang X, Karatepe K, Chiewchengchol D, Zhu H, Guo R, Liu P . Bacteria-Induced Acute Inflammation Does Not Reduce the Long-Term Reconstitution Capacity of Bone Marrow Hematopoietic Stem Cells. Front Immunol. 2020; 11:626. PMC: 7179742. DOI: 10.3389/fimmu.2020.00626. View

Gerosa R, Boettcher S, Kovtonyuk L, Hausmann A, Hardt W, Hidalgo J . CXCL12-abundant reticular cells are the major source of IL-6 upon LPS stimulation and thereby regulate hematopoiesis. Blood Adv. 2021; 5(23):5002-5015. PMC: 9153025. DOI: 10.1182/bloodadvances.2021005531. View

10.

Glienke W, Dragon A, Zimmermann K, Martyniszyn-Eiben A, Mertens M, Abken H . GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD and Releasing Inducible IL-18. Front Immunol. 2022; 13:839783. PMC: 8988144. DOI: 10.3389/fimmu.2022.839783. View

11.

Davila M, Bouhassira D, Park J, Curran K, Smith E, Pegram H . Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies. Int J Hematol. 2013; 99(4):361-71. PMC: 4684946. DOI: 10.1007/s12185-013-1479-5. View

12.

Kang Y, Yang S, Park G, Cho B, Min C, Kim T . A novel function of interleukin-10 promoting self-renewal of hematopoietic stem cells. Stem Cells. 2007; 25(7):1814-22. DOI: 10.1634/stemcells.2007-0002. View

13.

Post Y, Clevers H . Defining Adult Stem Cell Function at Its Simplest: The Ability to Replace Lost Cells through Mitosis. Cell Stem Cell. 2019; 25(2):174-183. DOI: 10.1016/j.stem.2019.07.002. View

14.

Florez M, Matatall K, Jeong Y, Ortinau L, Shafer P, Lynch A . Interferon Gamma Mediates Hematopoietic Stem Cell Activation and Niche Relocalization through BST2. Cell Rep. 2020; 33(12):108530. PMC: 7816211. DOI: 10.1016/j.celrep.2020.108530. View

15.

Drillet G, Lhomme F, de Guibert S, Manson G, Houot R . Prolonged thrombocytopenia after CAR T-cell therapy: the role of thrombopoietin receptor agonists. Blood Adv. 2022; 7(4):537-540. PMC: 9979763. DOI: 10.1182/bloodadvances.2022008066. View

16.

Wang H, Yu T, An N, Sun Y, Xu P, Han P . Enhancing regulatory T-cell function via inhibition of high mobility group box 1 protein signaling in immune thrombocytopenia. Haematologica. 2022; 108(3):843-858. PMC: 9973480. DOI: 10.3324/haematol.2022.281557. View

17.

Javier J, Hinge A, Bartram J, Xu J, Filippi M . Transforming growth factor-β signaling modifies the hematopoietic acute inflammatory response to drive bone marrow failure. Haematologica. 2021; 107(6):1323-1334. PMC: 9152956. DOI: 10.3324/haematol.2020.273292. View

18.

Li Y, Xue Z, Dong X, Liu Q, Liu Z, Li H . Mitochondrial dysfunction and oxidative stress in bone marrow stromal cells induced by daunorubicin leads to DNA damage in hematopoietic cells. Free Radic Biol Med. 2019; 146:211-221. DOI: 10.1016/j.freeradbiomed.2019.11.007. View

19.

Yan Y, Dong L, Chen C, Bunting K, Li Q, Stieglitz E . JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1β. Blood Adv. 2021; 6(1):200-206. PMC: 8753218. DOI: 10.1182/bloodadvances.2021005089. View

20.

Zhu C, Lian Y, Wang C, Wu P, Li X, Gao Y . Single-cell transcriptomics dissects hematopoietic cell destruction and T-cell engagement in aplastic anemia. Blood. 2021; 138(1):23-33. PMC: 8349468. DOI: 10.1182/blood.2020008966. View